Logo
search
  • Analytics
  • Backtesting
  • Options
  • Resources
  • Go Prime Go Prime
  • Menu
  • Menu

ABBOTINDIA

Current Price

29597.00-198.85 (-0.67%)

|

H: 30112.8

L: 29556.55

  • BSE: 500488
  • |
  • NSE: ABBOTINDIA
  • |
  • ISIN: INE358A01014
  • |
  • INDUSTRY: Pharmaceuticals

Open Price

29800

Prev. Close

29795.85

Price Table

* Prices are based on daily market changes.
DateOpenHighLowCloseVolumeDelivery %20-Day sma50-Day sma200-Day sma
13 Mar, 202529800.0030112.8029556.5529597.005,26822.6129949.8528736.1028404.00
12 Mar, 202530520.0030679.9529555.5529795.8511,26636.3929909.0028743.3528387.25
11 Mar, 202530620.1031103.8030394.3030496.509,37825.8329875.6528747.8028369.25
10 Mar, 202530768.3031099.9530125.0030629.6011,92628.6329835.0028732.7028347.30
07 Mar, 202530990.0031597.8030630.6530768.3012,12336.6229793.5028716.1528325.15
06 Mar, 202531500.0031573.2530659.3030983.1515,99143.8629709.1528686.1028303.50
05 Mar, 202531539.9031898.9530854.4531448.1020,71736.7129550.1028638.3528281.05

Day High Low Range

TimeLowestHighestVolume
09.30 AM29635.2029967.00761.00
09.45 AM29635.2030031.951147.00
10 AM29635.2030090.851389.00
11 AM29635.2030112.802264.00
12 PM29635.2030112.803343.00
1 PM29635.2030112.803672.00
2 PM29635.2030112.803961.00
3 PM29572.2030112.804594.00

Past Performance & Moving Averages

Day’sLow high rangeSMAStock performanceNifty performance
10 DAY
29115.00
-
31898.95
30683.760.23%2.12%
20 DAY
27549.90
-
31898.95
29949.853.73%-1.1%
50 DAY
25325.00
-
31898.95
28736.128.65%-2.22%
100 DAY
25325.00
-
31898.95
28634.156.53%-7.45%
200 DAY
25325.00
-
31898.95
28404.024.06%-9.67%
YTD
25325.00
-
31898.95
28784.30.63%-4.64%
52 Week
25200.00
-
31898.95
28052.228.04%-7.3%

PIVOT POINTS

NAMES4S3S2S1PIVOT POINTSR1R2R3R4
CLASSIC-28216.5528886.0529340.9530010.4530465.3531134.8531589.75-
WOODIE‘S--28832.4029233.6529956.8030358.0531081.20--
FIBONACCI-28886.0529315.3529580.9330010.4530439.9730705.5531134.85-
CAMARILLA29177.4329486.6429589.7129692.78-29898.9230001.9930105.0630414.27

CPR Levels

LTP: 29597.00
PDH: 30679.95
PDL: 29555.55
S4
28642.95
S3
28841.85
S2
29199.20
S1
29398.10
| CPR |
BC: 29676.23
P: 29755.45
TC: 29834.67
R1
29954.35
R2
30311.70
R3
30510.60
R4
30867.95
  • ABBOTINDIA is currently trading Below CPR levels which signifies Bearishness.
  • Today's CPR is comparatively Wider and unlikely to make a trending move today.
  • Day's opening range is 29635.2 ~ 29967.
  • Price is currently trading Inside the day's opening range.

Trend Analysis

Short term trend: Up
Medium term trend: Not Clear
Long term trend: Up

Key Data

Market capBook valuestock p/eDividend yieldroceroesales growth (3Y)face value (3Y)
62970.34 CR.1741.0049.101.48% 46.00% 34.90%11.00% 10.00

Profile

Abbott India Limited is a subsidiary of Abbott Laboratories, a global healthcare company based in the United States. The company was established in India in 1910 and is headquartered in Mumbai. Abbott India operates in the healthcare and pharmaceutical industry, offering a wide range of products and services including medical devices, diagnostics, and prescription drugs.

In terms of financials, Abbott India has shown strong performance over the years, with revenue and profits consistently growing. The company's primary sources of revenue come from the sale of prescription drugs and medical devices.

Abbott India operates in a highly competitive market, competing against other multinational and domestic pharmaceutical companies such as Pfizer, Novartis, and Cipla.

Here is a brief SWOT analysis for Abbott India:

Strengths:

  • Strong brand recognition and reputation in the healthcare industry
  • Extensive product portfolio, including both prescription drugs and medical devices
  • Strong research and development capabilities

Weaknesses:

  • Dependence on a limited number of key products for revenue
  • Exposure to regulatory and compliance risks in the highly regulated healthcare industry
  • Vulnerability to changes in government policies and regulations

Opportunities:

  • Expansion into new and emerging markets
  • Growing demand for healthcare products and services, especially in developing countries
  • Development of new and innovative products to meet the changing needs of customers

Threats:

  • Intense competition from established players in the industry
  • Changes in government regulations and policies, such as taxes and import duties
  • Potential for patent expirations and increased generic competition.

Please note that this is a general analysis and may not accurately reflect the current state of the company. It's important to conduct thorough research and consult with a financial advisor before making any investment decisions.